Published in Harv Rev Psychiatry on October 13, 2003
Methodological considerations regarding Joyce et al. 2016. Int J Bipolar Disord (2017) 0.81
Staging model raises fundamental questions about the nature of bipolar disorder. J Psychiatry Neurosci (2016) 0.79
Biological rhythms and mood disorders. Dialogues Clin Neurosci (2012) 0.78
Response to letters by Baethge et al. and Martino et al. Int J Bipolar Disord (2017) 0.75
International Society for Bipolar Disorders Task Force on Suicide: meta-analyses and meta-regression of correlates of suicide attempts and suicide deaths in bipolar disorder. Bipolar Disord (2014) 4.10
Sharing Clinical Trial Data: A Proposal From the International Committee of Medical Journal Editors. Ann Intern Med (2016) 3.95
Multiple versus single antipsychotic agents for hospitalized psychiatric patients: case-control study of risks versus benefits. Am J Psychiatry (2004) 3.76
Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. Am J Psychiatry (2007) 3.40
International consensus study of antipsychotic dosing. Am J Psychiatry (2010) 3.39
Sharing Clinical Trial Data--A Proposal from the International Committee of Medical Journal Editors. N Engl J Med (2016) 3.06
The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence. Am J Psychiatry (2003) 3.00
Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review. Bipolar Disord (2006) 2.74
Efficacy of antidepressants in juvenile depression: meta-analysis. Br J Psychiatry (2008) 2.44
Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety. J Clin Psychiatry (2010) 2.39
Illness risk following rapid versus gradual discontinuation of antidepressants. Am J Psychiatry (2010) 2.35
Sharing clinical trial data: a proposal from the International Committee of Medical Journal Editors. Lancet (2016) 2.25
Modern antipsychotic drugs: a critical overview. CMAJ (2005) 1.98
EEG abnormalities during treatment with typical and atypical antipsychotics. Am J Psychiatry (2002) 1.98
The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry (2013) 1.97
Pilot comparison of extended-release and standard preparations of divalproex sodium in patients with bipolar and schizoaffective disorders. Am J Psychiatry (2003) 1.84
Ecological studies of antidepressant treatment and suicidal risks. Harv Rev Psychiatry (2007) 1.78
Suicidal risk during treatment with clozapine: a meta-analysis. Schizophr Res (2005) 1.77
Inpatient antipsychotic drug use in 1998, 1993, and 1989. Am J Psychiatry (2002) 1.62
Weygandt's On the Mixed States of Manic-Depressive Insanity: a translation and commentary on its significance in the evolution of the concept of bipolar disorder. Harv Rev Psychiatry (2002) 1.60
Excessive mood elevation and behavioral activation with antidepressant treatment of juvenile depressive and anxiety disorders: a systematic review. Psychother Psychosom (2013) 1.50
Effects of newer antipsychotics on extrapyramidal function. CNS Drugs (2002) 1.50
ACNP Task Force report on SSRIs and suicidal behavior in youth. Neuropsychopharmacology (2006) 1.49
Precursors of bipolar disorders: a systematic literature review of prospective studies. J Clin Psychiatry (2015) 1.49
Reproductive decisions by women with bipolar disorder after prepregnancy psychiatric consultation. Am J Psychiatry (2002) 1.49
Spillover effects on treatment of adult depression in primary care after FDA advisory on risk of pediatric suicidality with SSRIs. Am J Psychiatry (2007) 1.49
Publish together or perish: the increasing number of authors per article in academic journals is the consequence of a changing scientific culture. Some researchers define authorship quite loosely. Dtsch Arztebl Int (2008) 1.48
Systematic review of blinding assessment in randomized controlled trials in schizophrenia and affective disorders 2000-2010. Psychother Psychosom (2013) 1.46
Effects of lithium on cognitive performance: a meta-analysis. J Clin Psychiatry (2009) 1.46
Neurocognitive impairment in bipolar disorder patients: functional implications. Bipolar Disord (2009) 1.46
Antidepressant treatment in bipolar versus unipolar depression. Am J Psychiatry (2004) 1.43
Sharing clinical trial data. BMJ (2016) 1.43
Suicide in bipolar disorder: Risks and management. CNS Spectr (2006) 1.43
Integration of suicidology with general medicine: an obligation to society. Patient Educ Couns (2011) 1.42
Cognition and disability in bipolar disorder: lessons from schizophrenia research. Bipolar Disord (2010) 1.41
Disability and its treatment in bipolar disorder patients. Bipolar Disord (2007) 1.39
Animal models of attention-deficit hyperactivity disorder. Brain Res Brain Res Rev (2003) 1.36
Circadian activity rhythm abnormalities in ill and recovered bipolar I disorder patients. Bipolar Disord (2008) 1.35
Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials. Neuropsychopharmacology (2010) 1.28
Suicide risk and treatments for patients with bipolar disorder. JAMA (2003) 1.26
Suicidal risk in antidepressant drug trials. Arch Gen Psychiatry (2006) 1.24
Impact factor--a useful tool, but not for all purposes. Dtsch Arztebl Int (2012) 1.23
Suicide rates in relation to health care access in the United States: an ecological study. J Clin Psychiatry (2006) 1.22
Epidemiology of tardive dyskinesia: is risk declining with modern antipsychotics? Mov Disord (2006) 1.18
Randomized, placebo-controlled trials of antidepressants for acute major depression: thirty-year meta-analytic review. Neuropsychopharmacology (2011) 1.18
Lithium treatment reduces suicide risk in recurrent major depressive disorder. J Clin Psychiatry (2007) 1.17
Episodes of mood disorders in 2,252 pregnancies and postpartum periods. Am J Psychiatry (2011) 1.14
McLean-Harvard International First-Episode Project: two-year stability of DSM-IV diagnoses in 500 first-episode psychotic disorder patients. J Clin Psychiatry (2008) 1.13
Recent progress in development of dopamine receptor subtype-selective agents: potential therapeutics for neurological and psychiatric disorders. Chem Rev (2007) 1.12
McLean-Harvard International First-Episode Project: two-year stability of ICD-10 diagnoses in 500 first-episode psychotic disorder patients. J Clin Psychiatry (2010) 1.11
Pediatric bipolar disorder: phenomenology and course of illness. Bipolar Disord (2004) 1.11
Is dose escalation of antidepressants a rational strategy after a medium-dose treatment has failed? A systematic review. Eur Arch Psychiatry Clin Neurosci (2005) 1.11
Overview of antidepressant treatment of bipolar depression. Int J Neuropsychopharmacol (2013) 1.10
Advances in development of dopaminergic aporphinoids. J Med Chem (2007) 1.10
Suicidal risk in bipolar I disorder patients and adherence to long-term lithium treatment. Bipolar Disord (2006) 1.08
Duloxetine: meta-analyses of suicidal behaviors and ideation in clinical trials for major depressive disorder. J Clin Psychopharmacol (2006) 1.07
Receptor affinities of dopamine D1 receptor-selective novel phenylbenzazepines. Eur J Pharmacol (2003) 1.06
Manic-depressive illness: evolution in Kraepelin's Textbook, 1883-1926. Harv Rev Psychiatry (2005) 1.06
Transparent texts: authors of scientific articles often have conflicts of interest. It is important for these to be communicated transparently to the readers. Dtsch Arztebl Int (2008) 1.05
Substance abuse in first-episode bipolar I disorder: indications for early intervention. Am J Psychiatry (2005) 1.04
Longitudinal neuroimaging and neuropsychological changes in bipolar disorder patients: review of the evidence. Neurosci Biobehav Rev (2013) 1.03
The languages of medicine. Dtsch Arztebl Int (2008) 1.02
Stargazin involvement with bipolar disorder and response to lithium treatment. Pharmacogenet Genomics (2008) 0.99
Lithium in breast milk and nursing infants: clinical implications. Am J Psychiatry (2007) 0.99
Parvalbumin neurons in the entorhinal cortex of subjects diagnosed with bipolar disorder or schizophrenia. Biol Psychiatry (2006) 0.98
Long-term lithium treatment in the prevention of suicidal behavior in bipolar disorder patients. Epidemiol Psichiatr Soc (2009) 0.98
Lithium augmentation therapy in refractory depression-update 2002. Eur Arch Psychiatry Clin Neurosci (2003) 0.98
Treatment-latency and previous episodes: relationships to pretreatment morbidity and response to maintenance treatment in bipolar I and II disorders. Bipolar Disord (2003) 0.98
Long-term effects of olanzapine, risperidone, and quetiapine on serotonin 1A, 2A and 2C receptors in rat forebrain regions. Psychopharmacology (Berl) (2002) 0.98
Prophylaxis latency and outcome in bipolar disorders. Can J Psychiatry (2003) 0.97
Effects of norepinephrine and serotonin transporter inhibitors on hyperactivity induced by neonatal 6-hydroxydopamine lesioning in rats. J Pharmacol Exp Ther (2002) 0.97
Hallucinations in bipolar disorder: characteristics and comparison to unipolar depression and schizophrenia. Bipolar Disord (2005) 0.97
Characteristics of patients diagnosed with schizoaffective disorder compared with schizophrenia and bipolar disorder. Bipolar Disord (2013) 0.96
Treatise on insanity in pregnant, postpartum, and lactating women (1858) by Louis-Victor Marcé: a commentary. Harv Rev Psychiatry (2009) 0.96
Long-term effectiveness of lithium in bipolar disorder: a multicenter investigation of patients with typical and atypical features. J Clin Psychiatry (2008) 0.95
Repeated antipsychotic drug exposure in developing rats: dopamine receptor effects. Synapse (2006) 0.95
Pilot randomized, controlled trial of pramipexole to augment antipsychotic treatment. Eur Neuropsychopharmacol (2011) 0.93
Regulation of working memory by dopamine D4 receptor in rats. Neuropsychopharmacology (2004) 0.93
Lithium treatment and suicide risk in major affective disorders: update and new findings. J Clin Psychiatry (2003) 0.93
Update 1 of: Recent progress in development of dopamine receptor subtype-selective agents: potential therapeutics for neurological and psychiatric disorders. Chem Rev (2013) 0.92
Antipsychotic drug use: McLean Hospital, 2002. Hum Psychopharmacol (2005) 0.92
Sequencing of substance use and affective morbidity in 166 first-episode bipolar I disorder patients. Bipolar Disord (2008) 0.92
Factors associated with functional recovery in bipolar disorder patients. Bipolar Disord (2010) 0.92
Use of combinations of antipsychotics: McLean Hospital inpatients, 2002. Hum Psychopharmacol (2005) 0.92
Enhanced expression of dopamine D(1) and glutamate NMDA receptors in dopamine D(4) receptor knockout mice. J Mol Neurosci (2004) 0.92
The virtues of correct citation: careful referencing is important but is often neglected/even in peer reviewed articles. Dtsch Arztebl Int (2011) 0.91
Suicidal events and accidents in 216 first-episode bipolar I disorder patients: predictive factors. J Affect Disord (2007) 0.91